US FDA’s Advertising Enforcement Crackdown Expands To Generic Drugs

 
• By Sue Sutter
  
TV set
The FDA sent untitled letters to AstraZeneca and SK Life Science for violative TV commercials. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance